Latest Commercialization News

Havilah Resources reports robust drilling, metallurgical, and mining study outcomes at its Mutooroo copper-cobalt-gold project, with JX Advanced Metals Corporation negotiating a pre-feasibility study agreement that could lead to equity investment.

Polymetals Resources reports steady progress at its Endeavor silver zinc mine with commissioning underway and first cash flow anticipated in June 2025. Mining volumes are ramping up ahead of schedule, setting the stage for a promising production phase.

Accent Resources has launched a Pre-Feasibility Study for its MagneƟte Range Project, aiming to produce premium magnetite concentrate tailored for modern steelmaking. This move positions the company to tap into growing demand for low-carbon steel inputs.

Estrella Resources has entered a landmark Master Agreement with Indonesian firm PT Raka Energi Mandiri, granting exclusive rights to market and purchase limestone from Timor-Leste, targeting sales of up to 500 million tonnes over five years.

Nimy Resources has raised $2.75 million through a share placement to fast-track exploration and resource definition at its promising Block 3 gallium discovery in Western Australia amid soaring global gallium prices.

Echo IQ’s application for a key US procedural code was rejected but the company plans a swift resubmission, maintaining confidence in its US commercial rollout.

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.

Yojee Limited has introduced its next-generation freight forwarding platform, MOSAIC, at the IFCBAA National Conference, aiming to disrupt traditional logistics software with AI-driven, community-focused technology.

Gibb River Diamonds has inked a pivotal mining contract with BML Ventures to kickstart open pit gold mining at its Edjudina Project, aiming for production as early as August 2025.

SEEK Limited projects strong FY25 revenue and earnings in the top half of guidance, driven by AI-powered product innovation and expanded market reach across Asia-Pacific.

LTR Pharma has appointed Associate Professor Darren Katz, a leading urologist and erectile dysfunction expert, to its Scientific Advisory Board, aiming to fast-track the development and commercialization of its innovative nasal spray treatments SPONTAN and ROXUS.

Nufarm reports a mixed 1H25 with strong crop protection gains offset by a sharp decline in seed technologies earnings, prompting a strategic review of its seed business amid omega-3 market challenges.